Navigation Links
Atrium Recognized by Business NH Magazine
Date:9/8/2010

HUDSON, N.H., Sept. 8 /PRNewswire/ -- Atrium Medical Corporation is proud to announce that it has been recognized by Business NH Magazine's September 2010 publication of Top 100 Private Companies in New Hampshire. The company has been ranked #12 of the fastest growing private firms in NH, and #9 overall in corporate revenue rankings based on last year's 2009 reported revenues. Atrium has placed prominently among the state's Top 100 private firms in size and rate of growth for the third year in a row.

According to the company's founder and CEO Steve Herweck, "Extraordinary profit and earnings growth, as well as incredible employee growth over the last 5 years is a result of management's commitment to organic and self funded developments in a broad spectrum of clinically relevant medical device technologies." These market leading products include proprietary items in Interventional Cardiology and Radiology, Vascular Surgery, BioSurgery, and Thoracic Surgery which are all designed, engineered and produced at its Hudson, New Hampshire manufacturing facility.

As Atrium approaches its 30th anniversary in early 2011 with plans for continued expansion in southern New Hampshire, this most recent corporate recognition affirms the company's MedTech legacy of enhanced patient outcomes in a highly regulated and diversified healthcare industry. The company's passion for innovation and quality are supported by its internally funded developments in innovation, employee training and advancement, evidence-based clinical trials, global logistics, state-of-the-art enterprise software operations and world class manufacturing.  

About Atrium

Atrium's vast expertise in medical device technologies for the treatment of coronary and vascular disease, chest trauma, hernia and soft tissue injury has brought a number of breakthrough advances in several diversified healthcare markets including interventional cardiology and radiology, chest trauma care and thoracic drainage, vascular surgery, and hernia repair. By maintaining a commitment to the latest ISO13485 Quality Standards, late breaking advancements in manufacturing and automation, cell biology and biomaterial research, Atrium continues to excel in those healthcare segments that require more advanced surgical intervention for life sustaining patient care. For more information please call Atrium's Marketing Communications Dept. at 1-800-370-7899 or visit Atrium's website at www.atriummed.com.


'/>"/>
SOURCE Atrium Medical Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Atrium Medical Corporation Announces First Implant of First-in-Man CINATRA(TM) Voclosporin Coated Coronary Stent
2. Atrium Responds to Bard Suit
3. FreshFx Recognized for use in the Scalder as a Solution to the Yield/Pathogen Reduction Dilemma
4. Corgenix AspirinWorks(R) Test Recognized in POLYCAP Study at ACC.09
5. invivodata Recognized as One of Pittsburghs Fastest Growing Private Companies
6. Roche Scientist Recognized for Excellence in Peptide Chemistry
7. SEI Defined Benefit Client Recognized With Leading Plan Design Award
8. Nonin Medical Recognized for Influential Contributions in Medical Technology
9. China Sky One Medical, Inc.s AMI Diagnostic Kit Recognized as a National Innovation Project by NDRC
10. AQUA(R) Technology Recognized as Promising New Strategy for Hormone Receptor Testing in Breast Cancer by NCCN Task Force
11. Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 Research and Markets ... - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage ... offering. ... drug delivery technologies will rise from USD 20 Billion in 2015 ... Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables ...
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
Breaking Medicine Technology:
(Date:4/24/2017)... DC (PRWEB) , ... April 24, 2017 , ... The ... recognized during ATA 2017: Telehealth 2.0 — the American Telemedicine Association’s annual conference, on ... Santana Telehealth Project for using telemedicine to improve the lives of the poor and ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin Welner has ... Research Award. The award honors scholars exemplary in their capacity to communicate important ... has demonstrated the capacity to deepen the public’s understanding and appreciation of the ...
(Date:4/24/2017)... ... 24, 2017 , ... The California Dental Association Foundation’s two-day volunteer dental clinic, ... people during the April 22-23 event at the San Mateo Event Center. , ... to care, CDA Cares educates the public and policymakers about the importance of good ...
(Date:4/24/2017)... Houston (PRWEB) , ... April 24, 2017 , ... The ... an innovative technology that allows anyone, anywhere to track their cognitive health, and share ... to check their own brain health on the museum's website. , BrainCheck founder, Dr. ...
(Date:4/24/2017)... ... April 24, 2017 , ... My T Chai, a ... products are now available for purchase on RevNutrition.com, a popular website specializing in sales ... produced and popularized in ancient India and Siam. It spread across Asia and Africa ...
Breaking Medicine News(10 mins):